Corporate news

Pharma customers gain access to both companies’ integrated design, development and manufacturing expertise Gerresheimer serves as central point of…

Major expansion in the North American market Supported by U.S. Biomedical Advanced Research and Development Authority (BARDA) via 70/30 cost-share…

Organic revenue growth of 13% in Q2 builds on strong Q1 performance Good momentum and strong order intake provide good visibility for second half …

Duesseldorf, July 4, 2022 – Gerresheimer has reached another milestone in the realization of its financing strategy by signing a revolving credit…

Partners join forces to improve lives of millions of Parkinson’s patients worldwide with a transformative technology-based solution Gerresheimer…

Duesseldorf, June 08, 2022 – The Annual General Meeting of Gerresheimer AG has approved the payment of a dividend of EUR 1.25 per share for the 2021…

Duesseldorf/Kosamba, May 16, 2022. Gerresheimer has significantly ramped up its glass and plastic production capacities in India to satisfy its global…

Partners are developing needle-free drug delivery platform for biologics and biosimilars This Innovative solution improves patient’s quality of…

First-quarter revenue grew organically by 19.1% Adjusted EBITDA up organically by 10.6% Gerresheimer raises revenue guidance to double-digit…